Come up with a name for your new list and we'll add to it:
Sirnaomics raised a round of funding on June 25, 2012. Investors include
National Institutes of Health.
Sirnaomics (圣诺制药) has developed a portfolio of intellectual properties in therapeutic areas of interest including anti-fibrotic medicine, cancer therapeutics, and others. STP705 is an anti-fib…